Showing results (621-630 of 749) with videos related to

Sort By:
Pageof 75
Cancer Genetics and Cytogenetics|September 1, 1997
DNA hypomethylation in breast cancer: an independent parameter of tumor progression?J Bernardino, C Roux, A Almeida, et al.
European Journal of Pediatrics|August 1, 1996
Abnormal cholesterol biosynthesis in the Smith-Lemli-Opitz and the lethal acrodysgenital syndromesV Cormier-Daire, C Wolf, A Munnich, et al.
Comptes Rendus Des Seances De La Societe De Biologie Et De Ses Filiales|January 1, 1997
[Cholesterol and development]C Roux, C Wolf, B Llirbat, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|October 12, 2007
Strontium ranelate prevents quality of life impairment in post-menopausal women with established vertebral osteoporosisP Marquis, C Roux, C de la Loge, et al.
Nanoimpact|December 12, 2022
Characterization of aerosolized particles in effluents from carbon fibre composites incorporating nanomaterials during simultaneous fire and impactR Chapple, C Chivas-Joly, J-C Roux, et al.
The American Journal of Pathology|December 1, 1994
Antibodies to the 280-kd coated pit protein, target of teratogenic antibodies, produce alterations in the traffic of internalized proteinsS Le Panse, E Ayani, N Mulliez, et al.
La Revue De Medecine Interne|December 8, 2006
[Abrupt onset of papulovesicular lesions: diagnostic features and outcome]V Doffoël-Hantz, A-L Fauchais, A Sparsa, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|December 4, 2014
Effect of certolizumab pegol over ninety-six weeks in patients with axial spondyloarthritis: results from a phase III randomized trialJ Sieper, R Landewé, M Rudwaleit, et al.
Osteoarthritis and Cartilage|February 26, 2008
The development of a short measure of physical function for hip OA HOOS-Physical Function Shortform (HOOS-PS): an OARSI/OMERACT initiativeA M Davis, A V Perruccio, M Canizares, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|July 4, 2015
A randomized, double-blind, placebo-controlled, sixteen-week study of subcutaneous golimumab in patients with active nonradiographic axial spondyloarthritisJ Sieper, D van der Heijde, M Dougados, et al.
Pageof 75